Advertisement
Australia markets close in 1 hour 55 minutes
  • ALL ORDS

    7,892.70
    -15.40 (-0.19%)
     
  • ASX 200

    7,636.10
    -16.70 (-0.22%)
     
  • AUD/USD

    0.6529
    -0.0012 (-0.18%)
     
  • OIL

    77.51
    -0.07 (-0.09%)
     
  • GOLD

    2,042.20
    +3.30 (+0.16%)
     
  • Bitcoin AUD

    86,462.37
    +7,672.91 (+9.74%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6015
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0605
    +0.0013 (+0.12%)
     
  • NZX 50

    11,651.88
    -58.02 (-0.50%)
     
  • NASDAQ

    17,933.33
    -4.27 (-0.02%)
     
  • FTSE

    7,684.30
    -21.98 (-0.29%)
     
  • Dow Jones

    39,069.23
    -62.27 (-0.16%)
     
  • DAX

    17,423.23
    +3.93 (+0.02%)
     
  • Hang Seng

    16,468.14
    -166.60 (-1.00%)
     
  • NIKKEI 225

    39,173.92
    -59.79 (-0.15%)
     

Here's What Key Metrics Tell Us About Phreesia (PHR) Q3 Earnings

For the quarter ended October 2023, Phreesia (PHR) reported revenue of $91.62 million, up 25.3% over the same period last year. EPS came in at -$0.58, compared to -$0.76 in the year-ago quarter.

The reported revenue represents a surprise of +2.56% over the Zacks Consensus Estimate of $89.33 million. With the consensus EPS estimate being -$0.72, the EPS surprise was +19.44%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Average healthcare services Clients: 3,688 versus 3,620 estimated by four analysts on average.

  • Average revenue per healthcare services client: $17.85 million versus the four-analyst average estimate of $18.18 million.

  • Patient payment volume: $965 million versus $1.01 billion estimated by three analysts on average.

  • Revenus- Subscription and related services: $42.60 million versus $42.32 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +29.1% change.

  • Revenus- Network solutions: $25.81 million versus $23.02 million estimated by five analysts on average.

  • Revenus- Payment processing fees: $23.22 million versus the five-analyst average estimate of $23.99 million. The reported number represents a year-over-year change of +18.3%.

View all Key Company Metrics for Phreesia here>>>

Shares of Phreesia have returned -1.9% over the past month versus the Zacks S&P 500 composite's +5.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Phreesia, Inc. (PHR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research